RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      Total Surface Area Is Useful for Differentiating between Aggressive and Favorable Multifocal Papillary Thyroid Carcinomas

      한글로보기

      https://www.riss.kr/link?id=A101617644

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: The purpose of the present study was to identify more useful parameters for predicting behaviors of multifocal papillary thyroid carcinoma (PTC). Materials and Methods: We investigated dominant tumor diameter (TD), total tumor diameter(TTD), ...

      Purpose: The purpose of the present study was to identify more useful parameters for predicting behaviors of multifocal papillary thyroid carcinoma (PTC). Materials and Methods: We investigated dominant tumor diameter (TD), total tumor diameter(TTD), and total surface area (TSA) in tumors from 588 patients and evaluated their usefulness as parameters for assessment of tumor behaviors in multifocal PTCs. Results: In 588 PTCs, tumor multifocality was found in 179 PTCs (30.4%). Multifocal tumors were significantly associated with extrathyroidal extension, lymph node metastasis, and higher tumor stage grouping (p<0.001, p<0.001, and p<0.001, respectively). The rates of nodal metastasis increased with greater TSA and TTD in PTCs. Multifocal papillary thyroid microcarcinomas (mPMCs) with TSA >3.14 cm2 had higher rates of nodal metastasis than mPMCs with TSA ≤3.14 cm2 (p=0.038); however, there was no significant difference between mPMCs with TTD >1.0 cm and with TTD ≤1.0 cm (p=0.325). In addition, nodal metastasis was more frequent in mPMCs with TSA >3.14 cm2 than in unifocal papillary thyroid microcarcinomas(uPMCs) (TD ≤1.0 cm) (p=0.002), but not overt unifocal PTCs (TD >1.0 cm) (p=0.244). Conclusion: Our results suggest that mPMCs with TSA >3.14 cm2 show more aggressive behavior than uPMCs and mPMCs with TSA ≤3.14 cm2. TSA could be useful in distinguishing aggressive mPMCs from favorable cases.

      더보기

      참고문헌 (Reference)

      1 Page C, "‘Aggressive papillary’ thyroid microcarcinoma" 266 : 1959-1963, 2009

      2 DeLellis RA, "World Health Organization Classification of Tumours. Pathology and genetics of tumours of endocrine organs" IARC Press 2004

      3 Connor MP, "Variables predictive of bilateral occult papillary microcarcinoma following total thyroidectomy" 144 : 210-215, 2011

      4 Siassakos D, "Thyroid microcarcinoma during thyroidectomy" 49 : 23-25, 2008

      5 Machens A, "The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma" 103 : 2269-2273, 2005

      6 Pyo JS, "The prognostic relevance of psammoma bodies and ultrasonographic intratumoral calcifications in papillary thyroid carcinoma" 37 : 2330-2335, 2013

      7 American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer" 19 : 1167-1214, 2009

      8 Kim HJ, "Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma" 78 : 614-620, 2013

      9 Ghossein R, "Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases" 24 : 245-253, 2014

      10 Mercante G, "Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients" 19 : 707-716, 2009

      1 Page C, "‘Aggressive papillary’ thyroid microcarcinoma" 266 : 1959-1963, 2009

      2 DeLellis RA, "World Health Organization Classification of Tumours. Pathology and genetics of tumours of endocrine organs" IARC Press 2004

      3 Connor MP, "Variables predictive of bilateral occult papillary microcarcinoma following total thyroidectomy" 144 : 210-215, 2011

      4 Siassakos D, "Thyroid microcarcinoma during thyroidectomy" 49 : 23-25, 2008

      5 Machens A, "The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma" 103 : 2269-2273, 2005

      6 Pyo JS, "The prognostic relevance of psammoma bodies and ultrasonographic intratumoral calcifications in papillary thyroid carcinoma" 37 : 2330-2335, 2013

      7 American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer" 19 : 1167-1214, 2009

      8 Kim HJ, "Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma" 78 : 614-620, 2013

      9 Ghossein R, "Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases" 24 : 245-253, 2014

      10 Mercante G, "Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients" 19 : 707-716, 2009

      11 Andea AA, "Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma" 94 : 1383-1390, 2002

      12 Haymart MR, "Papillary thyroid microcarcinomas: big decisions for a small tumor" 16 : 3132-3139, 2009

      13 Besic N, "Papillary thyroid microcarcinoma: prognostic factors and treatment" 97 : 221-225, 2008

      14 Hay ID, "Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period" 144 : 980-987, 2008

      15 Pelizzo MR, "Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients" 32 : 1144-1148, 2006

      16 Chow SM, "Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality" 98 : 31-40, 2003

      17 Appetecchia M, "Outcome after treatment of papillary thyroid microcarcinoma" 21 : 159-164, 2002

      18 Ciuffreda L, "Our experience on surgical treatment of papillary thyroid microcarcinoma" 32 : 41-44, 2011

      19 Pelizzo MR, "Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience" 25 : 547-552, 2004

      20 Katoh R, "Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients" 70 : 1585-1590, 1992

      21 Mazeh H, "Multifocality in well-differentiated thyroid carcinomas calls for total thyroidectomy" 201 : 770-775, 2011

      22 Zhao Q, "Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma" 20 : 746-752, 2013

      23 Rodríguez-Cuevas S, "Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population" 21 : 79-86, 2002

      24 Shattuck TM, "Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma" 352 : 2406-2412, 2005

      25 Ogilvie JB, "Impact of the 2009 American Thyroid Association guidelines on the choice of operation for well-differentiated thyroid microcarcinomas" 148 : 1222-1226, 2010

      26 Lin JD, "High recurrent rate of multicentric papillary thyroid carcinoma" 16 : 2609-2616, 2009

      27 Lee J, "Frequent, aggressive behaviors of thyroid microcarcinomas in Korean patients" 53 : 627-632, 2006

      28 Andea AA, "Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma" 100 : 20-27, 2004

      29 Lim YC, "Central lymph node metastases in unilateral papillary thyroid microcarcinoma" 96 : 253-257, 2009

      30 Moon WJ, "Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study" 247 : 762-770, 2008

      31 Park SY, "Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci" 107 : 1831-1838, 2006

      32 Voutilainen PE, "AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma" 23 : 4283-4288, 2003

      33 Edge SB, "AJCC Cancer Staging Manual" Springer-Verlag 87-100, 2009

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-05-31 학술지등록 한글명 : Yonsei Medical Journal
      외국어명 : Yonsei Medical Journal
      KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2000-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.42 0.3 0.99
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.72 0.546 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼